Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation

Hepatology International
Tomoki RyuHideki Saitsu

Abstract

The effects of achieving sustained virological response (SVR) on recurrence and survival after curative treatment in patients with hepatitis virus C (HCV)-related hepatocellular carcinoma (HCC) is unclear. This study examined the influence of SVR achievement by interferon therapy before HCC occurrence on recurrence and survival. This retrospective study included 518 patients who underwent surgical microwave ablation for initial HCV-related HCC between January 2001 and December 2015. Thirty-four patients had achieved SVR (SVR group) and 484 patients had not (control group). Clinical characteristics and long-term outcomes were compared between the two groups. Overall survival rates at 5 and 10 years after curative ablation were 95.8 and 80.4% in the SVR group, and 50.7 and 23.4% in the control, respectively (p < 0.0001). Recurrence-free survival rates at 5 and 10 years were 68.7 and 26.4% in the SVR group, and 24.5 and 7.8% in the control group, respectively (p < 0.0001). Multivariate analyses revealed that achieving SVR as an independent prognostic factor for both overall and recurrence-free survival. In the SVR group, the 5-year recurrence-free survival rates for patients with an interval of 5 years or fewer (n = 24) vs. more t...Continue Reading

References

Jan 1, 1996·Archives of Surgery·K TakenakaK Sugimachi
Dec 12, 2003·Lancet·Josep M LlovetJordi Bruix
Mar 31, 2004·Cancer Cell·Jordi BruixJosep M Llovet
May 27, 2005·Seminars in Liver Disease·Josep M LlovetVincenzo Mazzaferro
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vincenzo MazzaferroUNKNOWN HCC Italian Task Force
Oct 7, 2008·Journal of Hepato-biliary-pancreatic Surgery·Akira KobayashiTakenari Nakata
Feb 20, 2009·Journal of Gastroenterology·Takeji UmemuraKendo Kiyosawa
Jan 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia
Oct 24, 2009·Alimentary Pharmacology & Therapeutics·K NousoK Yamamoto
May 25, 2010·Journal of Gastroenterology and Hepatology·UNKNOWN Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma

❮ Previous
Next ❯

Citations

Sep 5, 2018·European Journal of Gastroenterology & Hepatology·Evangelos StournarasKonstantinos Tziomalos
Sep 2, 2019·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Tomoki RyuHideki Saitsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.